Let's talk medical research

While all clinical trial patient recruitment agencies can help support trial enrollment, they're not all created equal. While many companies offer a blend of services, there are still a few different distinct types of agencies that you'll run into while researching your options. Each have different strengths and weaknesses based on your patient population and the other needs of your trial. Take a ...

COPD, or chronic obstructive pulmonary disease, is the third-leading cause of death in the United States. Eleven million people in the U.S. have been diagnosed with COPD, and experts estimate that millions more may be undiagnosed.

Patient-centric clinical trial design begins with having conversations with patients. Though it's important to do this work in person, technology can help support your efforts, too. From study design to follow up, today's clinical trial tools offer more ways than ever to connect with patients who are actively interested in clinical trial participation, and keep them engaged throughout your trial.

The patient experience of traveling to clinical research sites, no matter the indication, can often be burdensome and time consuming. A variety of reasons can account for this experience, including lack of reliable transportation, associated travel costs or any possible physical obstacles the patient may face. Of all these concerns, though, one thing is certain: patient travel is proving ...

In our Delivering on Diversity series, we’ve spoken with Clinical Ambassador CEO and Founder Allison Kalloo about a variety of topics related to minority engagement in medical research.

It's a common belief that patients aren't interested in participating in clinical trials. Patient recruitment challenges appear to support this assumption – 80% of trials face delays because of recruitment, after all. But surveys from patient advocacy organizations like CISCRP show that at least 75% of patients are willing to take part in trials. So why is recruitment such a slow – and expensive ...

Even as online advertising has become more and more popular, some clinical trial sponsors and research sites remain hesitant to completely invest in it. In a small survey of research sites we conducted (n=55), just 27% used digital patient recruitment, and of them, only 9% cited it as their most successful channel. Misconceptions remain about digital recruitment, and while it is true that online ...

Patient engagement in clinical trials can help improve a troubling statistic: 30% of trial volunteers ultimately drop out of their study. Of course, patients are free to leave a clinical trial at any time, for any reason. But sites and sponsors do have some common reasons patients leave a trial, such as lack of appreciation for their participation and forgetting visits. Incorporate these tips ...

Clinical trials help people access tomorrow’s treatments today. In the age of precision medicine and tumor profiling, this statement is particularly true for oncology patients. According to a recent ProPublica article, even in Phase I trials, 20% of clinical trial participants now see a reduction in tumor size, compared with 5% of participants in the 1990s.

Of course, keeping patients engaged and on board with your trial is fundamental to its success. But the same goes for site staff, too. In fact, achieving a strong team dynamic with both of these stakeholders can determine the ultimate success of your study.